04:21 PM EST - Stellar Pharmaceuticals Inc. : is forecasting its third-quarter revenue will rise 35 per cent from a year ago, resulting in profitability. The London-based drugmaker said it expects product sales revenue to be up over 15 per cent from the same quarter in 2006, while royalty and licensing revenues are expected to increase by over 40 per cent. Stellar Pharmaceuticals Inc.
shares SLX:CA are trading down 0.005 cents at $0.43.
